Orphazyme launches investigation into dramatic and mysterious share price roller coaster

Orphazyme experienced significant turbulence on the US market on Thursday, where share price increases peaked at 1,400 percent with no explanation or forewarning. This rubbed off on the Danish exchange on Friday.

Photo: Orphazyme/PR

Prices of shares in biotech company Orphazyme have been through an inexplicable roller coaster since Thursday.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs